Furthermore, high HAb18G/CD147 expression was significantly correlated with high EGFR expression (Spearman r = 0.3086, P = 0.0016), suggesting that the high expression levels of both HAb18G/CD147 and EGFR might have important roles in promoting pancreatic cancer progression. Here, BSG is linked to pancreatic neoplasm.